The dose-limiting side effect of this drug is kidney toxicity. This interesting degree of success has led to the syntheses of large numbers of analogue structures for screening as potential second generation drugs, with the hope of finding coordination complexes with greater activity, less kidney toxicity, and increased solubility for administration in humans. Our laboratory has recently developed a new class of coordination complexes formed by reacting cis-diaquodiammineplatinum(II) with various pyrimidines and substituted pyrimidines (3). These complexes are, at present, poorly defined chemically, and they are all amorphous. They exhibit, however, potent antitumor activity in a number of tumor-host animal screens; they have a low toxicity [e.g., median lethal dose (LD50) 1000 mg/kg]; kidney toxicity is not the doselimiting side effect; and solubilities range up to 50% (by weight) as solutions in water. These complexes are highly colored, with hues ranging over green, blue, and purple.
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Early evidence from a number of laboratories has implicated the reaction of the platinum coordination complexes with DNA as the primary lesion in the cell responsible for the antitumor activity (4) . It is well known, however, that many of the simpler complexes also react with proteins, particularly with the sulfur-containing amino acids and with histidines (5) . The platinum-pyrimidine complexes interact avidly with nucleic acids, as has been shown in our laboratory (H. C. Pant and B. Rosenberg, personal communication) . For example, the addition of dilute (2.5 mM) solutions of the platinumpyrimidine complexes to DNA solutions causes rapid precipitation of deep blue stained DNA fibers. The reactions with RNA are somewhat slower, but still lead to the precipitation of blue stained RNA fibers. The stained and precipitated fibers of DNA contain about two tightly bound platinum atoms per phosphate. Rates of reactions of the platinumpyrimidine complexes with proteins are slower by a factor of at least 100.
Since these complexes are so highly soluble, deeply colored, and specific in their interactions with nucleic acids, it was of some interest to determine if they would show the same selectivity in animal cells. Incubation of such cells with the platinum-pyrimidine complexes does lead to a fairly rapid uptake of the blue stain by the cells, which can be discerned in normal light microscopy, but it is difficult to see more than an intensification of blue color in the nuclear region of the cells. Electron microprobe studies for the presence of platinum in the stained cells also indicated a preferential accumulation in the cell nucleus.
Since these drugs contain the heavy metal platinum, it was probable that their presence in cells could be seen by electron microscopy, without treatment with additional heavy metal atoms. Our first studies indicated that the platinum-pyrimidine complexes are useable cytologic stains for electron microscopy. They further verified the selectivity of interactions of the stains with nucleic acids, since only chromatin, the nucleolus, and ribosomes in the cytoplasm were made visible by the stain (6, 7) . When we expanded the number of different types of cells tested, we discovered an interesting new phenomenon, namely, the appearance of large patches of deeply stained material at the cell surfaces of tumorigenic cells. Such patches do not appear in normal cells or in transformed cells that are weakly or nontumorigenic. We report here the evidence showing the correlation between the appearance of cell surface stain using the platinum-pyrimidine complexes and the tumorigenicity of the cell types; and finally, the evidence in at least two instances suggesting that the stained surface sites are DNA. This is a preliminary communication and the full details will be presented elsewhere. For most experiments, the cells were fixed and stained. However, some experiments involved treatment of the cells with proteins before they were fixed and stained. This pretreatment consisted of incubation of the cells as a suspension in 1% (w/v) solutions of the proteins in phosphate-buffered saline at 37°. Aliquots of the cell suspensions were taken at various times and centrifuged for removal of the protein solutions by decanting. They were washed twice with phosphatebuffered saline. Controls were maintained in phosphatebuffered saline throughout the incubation period.
METHODS
All cells were fixed as a suspension at 40 for 1 hr in a 1% glutaraldehyde solution in 50 mM cacodylate buffer at pH 7.4. They were then stained for varying periods of time up to 1 hr in a 1% platinum-thymine (or uracil) complex in phosphatebuffered saline solution as a suspension at 4°. The cells were rinsed twice with a cold, equal volume mixture of acetone and water, and then dehydrated through a series of graded acetone/water solutions. After infiltration, the cells were embedded in Araldite 502 and sectioned for viewing directly under the electron microscope (Hitachi HUllE, operated at 75 kV). No other heavy metal postfixation treatment or counterstaining was performed.
Chemicals. The platinum-pyrimidine stains were freshly prepared in batches in our laboratory by R. G. Fischer and H. J. Peresie, and stored under reduced pressure. All batches were checked for similar quality by solubility and absorption spectroscopy criteria. All experiments included controls stained with the same batch. The stain solutions were freshly prepared and filtered through Whatman paper just prior to use. It is our experience that these stains are oxidized when exposed to air over long periods of time (weeks). (Figs. 1 and 2) . revealed. This is best illustrated for the endoplasmic reticulum, where the RNA-containing ribosomes are aligned in double rows while the membranous structures cannot be discerned (Fig. 2, inset) . These membranes, however, can be brought out when the sections are counterstained with membranous stains such as lead citrate. This contrast is further enhanced if double staining with uranyl acetate and lead citrate is used. These staining properties of the platinumpyrimidine complex are reproducible in every animal cell examined to date.
Since these complexes exhibit antitumor activity, we stained a number of different tumorigenic cells to investigate any staining features unique to tumor cells. We discovered that tumorigenic cells displayed extremely prominent electron-dense patches at the cell surface. It was quite easy to note these patches on any random thin section examined. One such stained cell type, the ascites sarcoma 180, is shown in Fig. 1 .
Cells from the normal tissues tested did not display these. patches, as is illustrated in Fig. 2 (Fig. 5) . These results have been duplicated with RNase from two different suppliers and DNase I from three different suppliers (see Methods). The effects of these enzyme pretreatments, coupled with the nucleic acid selectivity of the stain, suggest that the patches are DNA bound to the cellular plasma membrane and that neuraminic (sialic) acid is involved in this binding.
Treatment of the cells with RNase also causes a diminution in the intensity of staining of the ribosomes and nucleolus. The chromatin staining is unaffected by this treatment as far as we have been able to determine. Conversely, DNase I treatment causes an intensity diminution of the chromatin relative to the nucleolus and ribosomes, as well as the eradication of the surface patches.
We have also done some preliminary pretreatments of myeloma (MOPC), rat epithelial skin (RESI) (8) , and KB cells with DNase I and RNase. The RNase pretreatment had no effect on the electron-dense surface patches, consistent with our observations on the ascites sarcoma 180. The DNase I pretreatment markedly reduced these patches on the MOPC, but did not in the RESI or KB cells. Therefore, at this stage we cannot conclude that all tumorigenic cells are equally susceptible to removal of the patches by DNase I.
It is possible that the surface patches are either viruses or mycoplasma. Our observations of many cells lead us to believe ¶ We realize that it is difficult to characterize a cell line as tumorigenic since this requires that an immunologically competent host has been found in which a tumor will grow. To our knowledge, such a host has not been found for these four transformed cell lines. The American Type Culture Collection catalogue characterizes the KB line as used in tumorigenic studies, but does not so characterize the HeLa and the AV3 lines.
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Apart from the obvious questions raised by this work, if it is confirmed, we would feel remiss if we did not point to its potential applications, both in diagnosis and in providing a Cells were incubated at 370 in 1% protein in phosphate-buffered saline with the exception of trypsin, which was in a 0.25% solution.
The incubation times were 1 hr for hyaluronidase, 1 hr for neuraminidase, 3 hr for RNase, 3 hr for DNase I, 1 hr for concanavalin A (Con A), and 0.5 hr for trypsin.
new rationale for chemotherapy in cancer. Indeed, it already has been reported that DNase is effective against lymphatic leukemia in mice (10) .
